Edition:
United States

Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

129.98USD
12:15pm EST
Change (% chg)

$-1.51 (-1.15%)
Prev Close
$131.49
Open
$131.59
Day's High
$132.40
Day's Low
$129.25
Volume
449,200
Avg. Vol
2,665,187
52-wk High
$162.00
52-wk Low
$109.12

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Leonard Bell

57 2015 Chairman of the Board

David Brennan

63 2016 Interim Chief Executive Officer, Director

David Anderson

67 2016 Chief Financial Officer

Clare Carmichael

56 2014 Chief Human Resource Officer, Executive Vice President

John Moriarty

48 2014 Executive Vice President, General Counsel